Follow-up Messaging for Cancer

AH
KA
Overseen ByKathryn Anderson, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas Southwestern Medical Center
Must be taking: Chemotherapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if follow-up messages can help cancer patients use Oncology Acute Care (OAC) services more effectively after hospital discharge. Patients with active cancer who recently visited the Emergency Department (ED) after chemotherapy may receive automated MyChart and text messages to guide them on when to contact OAC services. The trial will compare patients receiving these messages with those receiving standard care instructions. It targets cancer patients treated with chemotherapy, who recently visited the ED, and use MyChart for health updates. As an unphased trial, this study offers patients the opportunity to contribute to research that could enhance post-discharge care for cancer patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on messaging and engagement with oncology care rather than medication changes.

What prior data suggests that this follow-up messaging intervention is safe for patients?

Research has shown that follow-up messages after hospital discharge are safe. For example, studies have found that automated text messages can reduce the need for emergency care without causing harm. In one study, patients who received these messages were 41% less likely to return to emergency care within 30 days. Another study demonstrated that text messaging programs were effective for patients recovering from cancer surgery.

These findings suggest that follow-up messages are well-received by patients and help them manage their care better. Reports of negative effects from these messaging systems are rare. Overall, the evidence supports follow-up messaging as a safe way to keep patients engaged in their healthcare and reduce unnecessary hospital visits.12345

Why are researchers excited about this trial?

Researchers are excited about follow-up messaging for cancer patients because it offers a proactive approach to patient care after hospital discharge. Unlike traditional care, which relies on standard discharge instructions, this method uses structured follow-up messages delivered through MyChart and automated text messaging at 24, 48, and 72 hours post-discharge. This innovative communication strategy aims to enhance patient engagement and potentially reduce emergency department visits by ensuring patients have timely access to essential educational materials and support.

What evidence suggests that follow-up messaging is effective for increasing patient engagement with Oncology Acute Care services?

Research has shown that follow-up messages after hospital discharge can reduce emergency room visits and readmissions. In this trial, participants in the intervention arm will receive structured follow-up messages using existing educational materials via MyChart and automated text messaging within 24, 48, and 72 hours post-discharge. One study found that follow-up appointments soon after discharge linked to a lower chance of returning to the hospital within 30 days. Another study showed that automated text messages reduced the need for urgent care by 41%. Follow-up messages also provide clear advice on when to seek urgent care. These findings suggest that organized follow-up can help patients manage their health better and avoid unnecessary hospital visits.35678

Who Is on the Research Team?

AH

Arthur Hong, MD, MPH

Principal Investigator

University of Texas Southwestern Medical Center

Are You a Good Fit for This Trial?

This trial is for adults (18+) with an active cancer diagnosis who are currently getting chemotherapy, have visited the ER within 30 days of treatment, were sent home after their visit or stay, and use MyChart with a valid phone number in English or Spanish.

Inclusion Criteria

I currently have an active cancer diagnosis.
I am currently receiving chemotherapy.
* ED Arrival within 30 days of chemotherapy treatment
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Randomization and Intervention

Patients are randomized into control or intervention arms. Intervention arm receives structured follow-up messages via MyChart and text messaging within 24, 48, and 72 hours post-discharge.

3 days per discharge event
No in-person visits required

Outcome Tracking

Patients are monitored for time to next cancer treatment-related ED visit and engagement with OAC services. Follow-up occurs in 3-month intervals.

2 years maximum

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months intervals

What Are the Treatments Tested in This Trial?

Interventions

  • Follow-up messaging

Trial Overview

The study tests whether sending follow-up messages through MyChart and text after hospital discharge helps cancer patients connect more with oncology acute care services. Patients are randomly assigned to usual care or receive these reminders.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ArmExperimental Treatment1 Intervention
Group II: Control Arm (Usual Care)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas Southwestern Medical Center

Lead Sponsor

Trials
1,102
Recruited
1,077,000+

Citations

Evaluation of post-discharge follow-up and clinical outcomes ...

To evaluate the effectiveness of an intervention designed to improve medication adherence, survival, and prevent rehospitalization through a ...

Association Between Postdischarge Medical Oncology ...

Timely postdischarge medical oncology appointments were associated with significantly lower likelihood of 30-day readmission and ED visits.

Effects of nurse-led telephone follow-up for discharged ... - PMC

Nurse-led telephone follow-up is effective in meeting information and psycho-social needs. We explored the potential effects of nurse-led telephone ...

Prompt Discharge Follow-Up Improves Transitions to ...

Prompt postdischarge follow-up was associated with decreased likelihood of ED visits and readmissions at 30 days in patients with cancer.

Effectiveness of Discharge Education Plan for Patients' ...

Clinically, the study highlights the critical role that discharge education plays in improving post- operative outcomes. ... Furthermore,.

Text Messaging After Gynecologic Cancer Surgery ...

The results of the pilot program demonstrated that text messaging programs for gynecologic oncology patients are feasible for offering efficient ...

Exploring two-way text messages for post-discharge follow-up ...

This study aims to evaluate a quality improvement (QI) initiative to improve caregiver response rates to an automated messaging system for post- ...

Automated Text Messaging to Reduce Use of Health Care ...

In this cohort study, an automated text message–based program was associated with a statistically significant 41% lower odds of 30-day use of acute care ...